CRL vs ABBV: Which Stock is Better?
Side-by-side comparison of Charles River Laboratories and AbbVie Inc in 2026
CRL
Charles River Laboratories
—
ABBV
AbbVie Inc
$227.23
Key Metrics Comparison
| Metric | CRL | ABBV | Winner |
|---|---|---|---|
| Market Cap | $7.78B | $334.34B | ABBV |
| P/E Ratio | N/A | 80.54 | ABBV |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CRL
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CRL or ABBV a better investment?
Comparing CRL and ABBV: Charles River Laboratories has a market cap of $7.78B while AbbVie Inc has $334.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CRL and ABBV?
CRL (Charles River Laboratories) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CRL or ABBV?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CRL or ABBV?
Both CRL and ABBV show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CRL or ABBV?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CRL or ABBV?
AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $7.78B for CRL.
Should I buy CRL or ABBV in 2026?
Both CRL and ABBV have investment merit. CRL trades at $N/A while ABBV trades at $227.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CRL and ABBV stock?
Key differences: Market Cap ($7.78B vs $334.34B), P/E Ratio (N/A vs 80.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CRL or ABBV in 2026?
The choice between CRL and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.0%). ABBV has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CRL and ABBV?
CRL (Charles River Laboratories) has a market cap of $7.78B, while ABBV (AbbVie Inc) has a market cap of $334.34B. ABBV is the larger company by market value.